TipRanks
Go Ultimate55% OFF

Austco Healthcare Limited (AHC) AI Stock Analysis

Top Page

AU:AHC

Austco Healthcare Limited

(ASX:AHC)

Select Model
Rating:70Outperform
Price Target:AUD 0.31â–²(10.00% Upside)
Action:reiterated
Date:10/17/26

The score is primarily driven by solid fundamentals—strong growth, improving net profitability, and a very low-debt balance sheet—partly offset by margin volatility and uneven cash flow consistency. Technical indicators are neutral-to-mixed (below the 200-day with a negative MACD), while valuation looks supportive with a low P/E.

Positive Factors
Accelerating revenue growthRapid revenue acceleration indicates stronger adoption of Austco’s healthcare communication and workflow solutions across its served markets. If sustained, this broader commercial scale can support operating leverage, deepen customer relationships, and provide a larger base for future earnings growth.
Negative Factors
Gross margin compressionThe sharp gross-margin decline suggests that revenue growth is currently accompanied by less favorable economics at the gross-profit level. If the pressure persists, it could limit operating leverage, reduce the benefit of scale, and make future earnings more sensitive to mix or fulfillment costs.

Austco Healthcare Limited (AHC) vs. iShares MSCI Australia ETF (EWA)

-60%-50%-40%-30%-20%-10%0%10%20%AU:AHC-36.36%EWA+13.51%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
AUD 104.93M
Dividend Yield
―
Average Volume (3M)
213.92K
Price to Earnings (P/E)
11.6
Beta (1Y)
0.69
Revenue Growth
15.77%
EPS Growth
48.47%
Country
Australia
Employees
102
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Austco Healthcare Limited Business Overview & Revenue Model

Company Description

Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends acros...

Austco Healthcare Limited Financial Statement Overview

Summary

Strong revenue acceleration into 2026 and improved net profitability, supported by a conservative, low-leverage balance sheet and healthy ROE. Offsetting factors are sharp 2026 gross margin compression and weaker free cash flow growth/coverage consistency despite positive FCF.

Income Statement

78Positive

Balance Sheet

86Very Positive

Cash Flow

62Positive
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue94.24M94.24M81.41M58.15M41.98M35.88M
Gross Profit20.96M20.96M42.37M30.67M6.68M18.85M
EBITDA14.73M14.80M13.46M8.11M3.60M3.73M
Net Income9.01M9.01M5.93M7.08M2.26M2.33M
Balance Sheet
Total Assets88.50M88.50M91.07M68.70M37.85M34.03M
Cash, Cash Equivalents and Short-Term Investments16.28M16.28M14.48M13.56M4.67M7.63M
Total Debt3.95M3.95M3.88M1.78M524.00K979.00K
Total Liabilities26.38M26.38M39.34M24.33M12.85M10.94M
Stockholders Equity62.12M62.12M51.73M44.38M25.00M23.09M
Cash Flow
Free Cash Flow11.72M11.72M10.66M7.45M-1.25M315.00K
Operating Cash Flow12.51M12.51M13.42M11.35M320.00K1.94M
Investing Cash Flow-8.82M-8.82M-12.32M-11.06M-1.57M-1.63M
Financing Cash Flow-1.43M-1.43M-402.00K8.84M-1.58M-312.00K

Austco Healthcare Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price0.28

Price Trends

50DMA0.25Positive
100DMA0.24Positive
200DMA0.29Negative

Market Momentum

MACD0.01Negative
RSI63.96Neutral
STOCH73.89Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHC, the sentiment is Positive. The current price of 0.28 is above the 20-day moving average (MA) of 0.26, above the 50-day MA of 0.25, and below the 200-day MA of 0.29, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 63.96 is Neutral, neither overbought nor oversold. The STOCH value of 73.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:AHC.

Austco Healthcare Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

AU:AHC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AU:AHCAU:AHC70OutperformAUD 104.93M11.5714.90%―15.77%48.47%
AU:ALCAU:ALC63NeutralAUD 148.48M64.702.53%―26.61%41.67%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
AU:ONEAU:ONE48NeutralAUD 109.10M-6.40-203.69%―-1.53%28.29%
AU:BMTAU:BMT45NeutralAUD 21.26M-1.14-58.13%―2.08%-195.31%
AU:M7TAU:M7T43NeutralAUD 61.10M-6.84-24.29%―-17.35%-47.29%
AU:PGCAU:PGC39UnderperformAUD 256.57M-16.14-5.34%―1.84%-178.23%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%AU:AHCAU:ONEAU:M7TAU:PGCAU:BMTAU:ALCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
AU:AHC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:AHCAustco Healthcare Limited0.28-0.15-35.63%
AU:ONEOneview Healthcare PLC Chess Depository Interests repr 10.13-0.06-31.58%
AU:M7TMach7 Technologies Ltd.0.26-0.04-13.33%
AU:PGCParagon Care Limited0.15-0.17-51.56%
AU:BMTBeamtree Holdings Ltd0.07-0.15-67.27%
AU:ALCAlcidion Group Limited0.110.0222.22%

Austco Healthcare Limited Corporate Events

Austco grants new performance rights to managing director Clayton Astles

Oct 21, 2026

Austco Healthcare Limited has updated the market on a change in the securities held by managing director Clayton Astles. The disclosure details his direct and indirect holdings in ordinary shares and unlisted performance rights, reflecting his equity...

Austco Healthcare Shareholders Back All AGM Resolutions

Oct 19, 2026

Austco Healthcare Limited reported the results of its Annual General Meeting held on 19 October 2026, where shareholders strongly supported all resolutions put to the vote. Key items, including the adoption of the remuneration report, the re-election...

Austco Healthcare Delivers Record FY26 Results on Digital Health Growth

Oct 19, 2026

Austco Healthcare reported a record financial year in FY26, delivering revenue of $94.2 million, up 15.8%, and EBITDA growth of 14%, while integrating three acquired businesses. Software and maintenance revenue rose 19% to $11.4 million, lifting its...

Austco Healthcare Grants New Performance Rights and Seeks Shareholder Approval for Additional Equity Incentives

Sep 30, 2026

Austco Healthcare Limited has granted 2,548,312 Performance Rights under its Share Incentive Plan, covering a performance period from 1 July 2026 to 30 June 2029. The rights will vest based on a mix of earnings per share growth targets and indexed to...

Austco Healthcare Issues New Unquoted Performance Rights Under Incentive Scheme

Sep 30, 2026

Austco Healthcare Limited has notified the market of the issue of 2,548,312 unquoted performance rights under its employee incentive scheme, effective 1 October 2026. These securities, which will not be quoted on the ASX, form part of Austco’s...

Austco Director Increases Shareholding After Performance Rights Vesting

Sep 28, 2026

Austco Healthcare Limited has disclosed a change in the holdings of director Clayton Astles following the vesting of performance rights under the company’s employee share scheme. Astles received 677,486 ordinary shares transferred from the Aust...

Austco Healthcare Issues 2.7 Million New Shares on Conversion of Unquoted Securities

Sep 28, 2026

Austco Healthcare Limited has notified the market that 2,730,877 ordinary fully paid shares have been issued following the exercise or conversion of previously unquoted equity securities. The issuance of these additional shares on 28 September 2026 i...

Austco Alters Employee Share Plan to Allow On-Market Share Acquisition via Trust

Sep 18, 2026

Austco Healthcare has amended its Employee Share Incentive Plan to allow shares to be acquired, including on-market, and transferred to eligible participants via a share trust administered by Computershare’s CPU Share Plans Pty Ltd. The board u...

Austco Healthcare lifts profit and pipeline as acquisition integration drives growth

Sep 17, 2026

Austco Healthcare reported another year of growth for the 2026 financial year, with revenue rising 16% to a record $94.2 million and statutory net profit after tax jumping 52% to $9.0 million, supported by margin improvement and the full-year contrib...

Austco Healthcare to Hold Fully Virtual AGM in October 2026

Sep 17, 2026

Austco Healthcare Limited has called its Annual General Meeting for 19 October 2026, opting to conduct the event entirely online in line with legislative changes that permit virtual shareholder meetings. Using the Computershare platform, shareholders...

Austco Healthcare Delivers Record Revenue and Margin Gains in FY26

Aug 27, 2026

Austco Healthcare reported record FY26 customer revenue of $94.2 million, up 16% year on year, with EBITDA rising 14% to $14.9 million and NPAT surging 52% to $9.0 million, supported by a $51.2 million pipeline of unfilled contracted revenue. Perform...

Austco Healthcare Profit Jumps 52% on Strong Revenue Growth

Aug 27, 2026

Austco Healthcare Limited reported a 15.8% rise in revenue to $94.2 million for the year ended 30 June 2026, with EBITDA up 14.0% to $14.8 million and EBIT rising 7.0% to $10.9 million. Net profit after tax surged 51.8% to $9.0 million, supported by...

Austco Healthcare strengthens South Australian presence with MCS acquisition

Aug 13, 2026

Austco Healthcare Limited has completed the acquisition of Medical Communications Systems, its long-standing certified nurse call reseller in South Australia, bringing the reseller in-house after a relationship dating back to 2011. MCS, which has 12...

Austco Healthcare buys South Australian reseller in earnings-accretive deal

Aug 9, 2026

Austco Healthcare has agreed to acquire 100% of Medical Communications Systems, its long-standing certified nurse call reseller in South Australia, bringing the operation in-house. The deal continues Austco’s reseller acquisition strategy and i...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 17, 2026